ChatGPT’s Birthday Message; Journal Softens on AI; Healthcare AI Tracker

Welcome to MedAI Roundup, highlighting the latest news and research in healthcare-related artificial intelligence each month.

ChatGPT wrote about turning a year old. Here’s how the AI chatbot has since made an impact on healthcare. (NPR and Axios)

And that’s just the beginning: ChatGPT parent company OpenAI said it has started development with Microsoft on the next-generation AI model, GPT-5. Notably, OpenAI CEO Sam Altman is back at the company after a tumultuous exit. (Financial Times and New York Times)

Science has updated its AI editorial policy to now permit some exceptions for using AI-generated images and videos in manuscripts.

STAT has developed a tracker of health systems and healthcare companies that are leading adoption of generative AI in medicine.

Yet another study has shown that generative AI models are capable of writing very convincing clinical notes that are hard to distinguish from physician-written notes, according to a paper published in NPJ Digital Medicine.

However, Nigam Shah, MBBS, PhD, Stanford Health Care’s chief data scientist, warned that AI-powered clinical support tools require carefully selected data to operate effectively and without bias, according to an interview with JAMA editor-in-chief Kirsten Bibbins-Domingo, MD, PhD.

Similarly, researchers at the Dana-Farber Cancer Institute issued a warning about the ethical implications of using patient-facing AI tools in a study published in JCO Oncology Practice.

The American Medical Association’s board also recently approved the association’s principles for the development and use of AI in healthcare, which focus primarily on transparency, oversight, and data privacy and security.

Still, only 13% of medical group leaders reported AI as their top tech priority, according to an MGMA poll of 424 healthcare leaders. Ensuring usability of electronic medical records was the top tech priority, at 35% of respondents.

The Department of Veterans Affairs launched a new $1 million competition to encourage researchers to create AI-enabled tools that can address burnout among healthcare workers.

Michael DePeau-Wilson is a reporter on MedPage Today’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news. Follow

Chinese imports of common cancer drug run dry, FDA says

China’s Qilu Pharmaceutical has distributed all of the chemotherapy cisplatin that was imported as a result of the shortage of the common cancer drug. The

September 20, 2023

FDA Approves TriClip; Fortified Eggs vs Cholesterol; Impella Maker Chided

Abbott said its TriClip transcatheter edge-to-edge repair system snagged FDA approval for treating for tricuspid regurgitation. Medtronic announced that the FDA approved the Evolut FX+

April 3, 2024

UCB’s BIMZELX gains FDA approval for inflammatory conditions

The product is indicated to treat active psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis. Credit: Oporty786/Shutterstock. Biopharmaceutical company UCB has received US Food and

September 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.